RETATRUTIDE: ONE COMPARATIVE EXAMINATION

The emerging class of GLP-1 receptor agonist and GIP combined medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, represent groundbreaking advances in the control. Although all three function by impacting sugar concentrations, they distinguish in their specific mecha